Diabetes Market Research Reports & Industry Analysis
Glucose monitors have a major consumer-marketing component. While physicians may prescribe a monitor, the patient ultimately has the choice of which monitor s/he uses. Insulin provides very little consumer choice. The treatment regimen prescribed by the physician must be followed and there are very few market options. With Eli Lilly and Novo Nordisk being the two largest producers of insulin, it is highly likely that an insulin user will wind up using one of their products. As time goes by, the options of oral insulin and more intranasal insulin products may offer insulin dependent diabetics more variety in terms of products and delivery methods.
Hypoglycemic agents abound and vary in their composition and mode of action. For the most part, advanced cases of Type 2 diabetes require more than one of these drugs in order for the patient to maintain glycemic control. Because of the wide variety of these products, there is some room for pharmaceutical companies to influence diabetics toward using their products. In the end, the physician may have the last word, but that does not mean that the patient will stay with a physician who does not acquiesce to his/her wishes.
Diabetes Industry Research & Market Reports
-
Asia Pacific Blood Glucose Monitoring Market Research Report Information, By Product Type (Invasive Glucose Monitoring, Flash Glucose Monitoring, and CGM), By Application (Type 1 Diabetes, and Type 2 Diabetes), By End-User (Diagnostics Center, Hospitals, and Clinics), And, By Region (Asia-Pacific) –Industry Forecast till 2032
... Clinics), And, By Region (Asia-Pacific) –Industry Forecast till 2032 The Asia Pacific Blood Glucose Monitoring Market was valued at USD 1.1 billion in 2022. The Asia Pacific Blood Glucose Monitoring market is expected to increase ... Read More
-
Insulin Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
... and Countries, Regulatory Path and Key Companies, 2024 Update provides comprehensive information about the Insulin Delivery pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials ... Read More
-
Global Blood Glucose Monitoring Devices Market - Focused Insights 2024-2029
... Blood Glucose Monitoring Systems Diabetes become the leading cause of death; so far, there are no effective treatments to prevent and cure diabetes, so reasonable blood glucose monitoring devices become a major choice. It led ... Read More
-
Germany Diabetes Device Market Forecast Report by Types (Self-Monitoring Devices, Continuous Glucose-Monitoring Devices, Insulin Pumps, Insulin Pens), End User (Hospitals, Diagnostics Centers, Homecare) and Company Analysis 2024-2032
... Device market is expected to reach US$ 1.39 Billion in 2023 to US$ 2.62 Billion by 2032, with a CAGR of 7.30 % from 2024 to 2032. The wide variety of applications available for diabetes ... Read More
-
United States Diabetes Device Market Forecast Report by Types (Self-Monitoring Devices, Continuous Glucose-Monitoring Devices, Insulin Pumps, Insulin Pens), End User (Hospitals, Diagnostics Centers, Homecare), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Diabetes Clinics/Centers, Online Pharmacies) and Company Analysis 2024-2032
... Company Analysis 2024-2032 United States Diabetes Device Market Size The United States Diabetes Device market is expected to reach US$ 8.67 Billion in 2023 to US$ 16.25 Billion by 2032, with a CAGR of 7.23 ... Read More
-
United Kingdom Diabetes Device Market Forecast Report by Types (Self-Monitoring Devices, Continuous Glucose-Monitoring Devices, Insulin Pumps, Insulin Pens), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Diabetes Clinics/Centers, Online Pharmacies) and Company Analysis 2024-2032
... Device Market Size The United Kingdom Diabetes Device market is expected to reach US$ 1.05 Billion in 2023 to US$ 2.00 Billion by 2032, with a CAGR of 7.42 % from 2024 to 2032. Better ... Read More
-
Netherlands Diabetes Device Market Forecast Report by Types (Self-Monitoring Devices, Continuous Glucose-Monitoring Devices, Insulin Pumps, Insulin Pens), End User (Hospitals, Diagnostics Centers, Homecare) and Company Analysis 2024-2032
... Device market is expected to reach US$ 343.4 Million in 2023 to US$ 641.7 Million by 2032, with a CAGR of 7.19 % from 2024 to 2032. The market for diabetic devices in the Netherlands ... Read More
-
Japan Diabetes Device Market Forecast Report by Types (Self-Monitoring Devices, Continuous Glucose-Monitoring Devices, Insulin Pumps, Insulin Pens), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Diabetes Clinics/Centers, Online Pharmacies) and Company Analysis 2024-2032
... Size The Japan Diabetes Device market is expected to reach US$ 1.46 Billion in 2023 to US$ 2.80 Billion by 2032, with a CAGR of 7.50 % from 2024 to 2032. The market is growing ... Read More
-
Blood Glucose Monitoring Systems
... reach US$40.0 Billion by 2030, growing at a CAGR of 9.8% over the analysis period 2023-2030. Self-Monitoring, one of the segments analyzed in the report, is expected to record a 9.3% CAGR and reach US$21.4 ... Read More
-
Digital Diabetes Management
... at a CAGR of 18.6% over the analysis period 2023-2030. Digital Diabetes Management Devices, one of the segments analyzed in the report, is expected to record a 18.5% CAGR and reach US$46.7 Billion by the ... Read More
-
Insulin Storage Devices
... at a CAGR of 7.3% over the analysis period 2023-2030. Battery Operated Devices, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$996.0 Million by the end ... Read More
-
Human Insulin
... CAGR of 6.7% over the analysis period 2023-2030. HI Drugs, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$70.6 Billion by the end of the analysis ... Read More
-
Europe Retinal Surgery Devices Market Report Forecast By Product (Vitrectomy Machines, Vitrectomy Packs, Surgical Instruments, Microscopic Illumination Equipment, Retinal Laser Equipment, Others), Application (Diabetic Retinopathy, Retinal Detachment, Epiretinal Membrane, Macular Hole, Others), End User (Hospitals, Eye Clinics, Others), Countries and Company Analysis (2024-2032)
... Eye Clinics, Others), Countries and Company Analysis (2024-2032) Europe Retinal Surgery Devices Market Analysis The Europe Retinal Surgery Devices Market will reach US$ 1,164.93 million by 2032, up from US$ 633.03 million in 2023, with ... Read More
-
Insulin Patch Pumps
... at a CAGR of 9.8% over the analysis period 2023-2030. Basal & Bolus Delivery Mode, one of the segments analyzed in the report, is expected to record a 9.5% CAGR and reach US$1.4 Billion by ... Read More
-
Nocturia Drugs
... at a CAGR of 6.1% over the analysis period 2023-2030. Low Nocturnal Bladder Capacity Indication, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$3.0 Billion by ... Read More
-
China Diabetes Device Market Forecast Report by Types (Self-Monitoring Devices, Continuous Glucose-Monitoring Devices, Insulin Pumps, Insulin Pens), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Diabetes Clinics/Centers, Online Pharmacies) and Company Analysis 2024-2032
... Size The China Diabetes Device market is expected to reach US$ 6.22 Billion in 2023 to US$ 12.74 Billion by 2032, with a CAGR of 8.29 % from 2024 to 2032. Recent decades have seen ... Read More
-
France Diabetes Device Market Forecast Report by Types (Self-Monitoring Devices, Continuous Glucose-Monitoring Devices, Insulin Pumps, Insulin Pens), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Diabetes Clinics/Centers, Online Pharmacies) and Company Analysis 2024-2032
... Size The France Diabetes Device market is expected to reach US$ 946.9 Million in 2023 to US$ 1,784.6 Billion by 2032, with a CAGR of 7.30 % from 2024 to 2032. The market for diabetes ... Read More
-
Blood Glucose Meters
... at a CAGR of 6.7% over the analysis period 2023-2030. Self-Monitoring Blood Glucose Meters, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$36.8 Billion by the ... Read More
-
Computer-aided Drug Discovery Market: Global Market Size, Forecast, Insights, and Competitive Landscape
... drug discovery market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global computer-aided drug discovery market by segmenting ... Read More
-
Inborn Gene or Chromosome Alterations Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
... including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Inborn Gene or Chromosome Alterations pipeline products with comparative analysis of the products at various ... Read More
-
Empagliflozin, Dapagliflozin And Canagliflozin Global Market Report 2024 Including: 1) By Type: Empagliflozin; Dapagliflozin; Canagliflozin 2) By Application: Application I; Application II; Application III; Application IV 3) By Channel: Hospital; Pharmacy Covering: Pfizer Inc.; Merck & Co. Inc.; Sanofi S.A.; Bristol-Myers Squibb Company; AstraZeneca PLC
... Sanofi S.A.; Bristol-Myers Squibb Company; AstraZeneca PLC Empagliflozin, Dapagliflozin And Canagliflozin Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the ... Read More
-
Pharmaceutical Drug Delivery Market by Route of Administration [Oral, Injectors (Pen, Auto Injectors) Implantable, Syrups, Gels, Pulmonary, Tablets, Syringes], Application (Cancer, Diabetes), Facility of Use (Hospital, Home Care) -Global Forecast to 2029
... drug delivery market is projected to reach USD 2,546.0 billion by 2029 from USD 1,949.4 billion in 2024 at a CAGR of 5.5% during the forecast period. The rapid growth in the geriatric population globally ... Read More
-
Artificial Pancreas Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
... and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Artificial Pancreas pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials ... Read More
-
Drug Device Combination Products Market Report by Product (Drug Eluting Stents, Transdermal Patches, Infusion Pumps, Drug Eluting Balloon, Inhalers, and Others), Application (Cardiovascular, Diabetes, Cancer Treatment, Respiratory Diseases, and Others), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Region 2024-2032
... Centers, and Others), and Region 2024-2032 The global drug device combination products market size reached US$ 155.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 284.9 Billion by 2032, exhibiting ... Read More
-
Rapid Acting Insulin Market Report by Product (Lispro Insulin, Aspart Insulin, Glulisine Insulin), Indication (Type 1 Diabetes, Type 2 Diabetes), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, Online Stores), and Region 2024-2032
... global rapid acting insulin market size reached US$ 7.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 11.2 Billion by 2032, exhibiting a growth rate (CAGR) of 4.1% during 2024-2032. ... Read More
Research Assistance
